1. Introduction {#s0005}
===============

Rotaviruses, belonging to the *Reoviridae* family are large non-enveloped viruses, consisting of triple layered particles which surround the viral genome composed of 11 segments of double-stranded RNA ([@b0035]). The rotaviruses are major pathogens that cause severe, acute dehydrating gastroenteritis in young children and in a wide variety of domestic animals ([@b0035], [@b0040], [@b0045]). Specifically, rotaviruses cause severe diarrheal diseases in neonatal and post-weaning piglets and calves ([@b0035]).

The anti-rotavirus effects of some commercially available antiviral drugs such as ribavirin, interferon, dipyridamole, cimentidine, and famodine have been examined *in vitro* and in animal experiments ([@b0055]) and have shown anti-rotavirus activities ([@b0085], [@b0115], [@b0130]). Dipyridamole has also been reported to possess antiviral activity against representatives of other virus families (*e.g.,* Picornaviridae, Togaviridae, Orthomyxoviridae, Paramyxoviridae, Herpesviridae, and Poxviridae) ([@b0085], [@b0115], [@b0130]). Cimentidine and famodine do not only have anti-HIV activity, but also exhibit therapeutic effects against herpes simplex virus infection ([@b0020], [@b0070]). Although these drugs act by inhibiting rotavirus replication and adsorption, any side-effects have not been examined in clinical studies. Immunoglobulins have also been used to treat diarrhea caused by rotaviruses; however, these drugs are very costly and the side-effects are unknown ([@b0060], [@b0100], [@b0140]). Antiviral agents from natural sources such as black tea, *Citrus aurantium*, marine sponges, soy, and *Stevia rebaudiana* were considered as ideal drug candidates because they are less toxic, have fewer side-effects, and cheaper, but may have more effective reaction than those commercially available anti-rotavirus agents ([@b0005], [@b0010], [@b0025], [@b0030], [@b0120]). However, these drugs are not currently available for human or animal use. Nevertheless, the diarrhea caused by rotaviruses remains uncontrolled, thus new drugs are urgently needed to control rotavirus infection.

*Alpinia katsumadai* Hayata (Zingiberaceae) (AK) has been utilized as a traditional Chinese herbal drug for its anti-emetic and stomachic mechanism of action ([@b0125]). It has been reported to contain a variety of diarylheptanoids, monoterpenes, sesquiterpenoid, flavonoids, and chalcones as major constituents ([@b0080], [@b0105], [@b0135]). The extracts and compounds isolated from this plant have shown anti-emetic activity and a plasma cholesterol-lowering effect by cholesterol esterase inhibitory activity, and anti-oxidant activity ([@b0075], [@b0090], [@b0135]). Recently, compounds isolated from this plant showed *in vitro* neuraminidase inhibitory activities against human influenza virus A/PR/8/34 of subtype H1N1 and four H1N1 swine influenza viruses with antiviral effects in plaque reduction assays ([@b0050]). However, to date the anti-rotavirus activities of the extracts and compounds isolated from this plant have not been previously evaluated. Therefore, in this study, we have found the *in vitro* anti-rotaviral activity of AK extracts and its mechanism of anti-rotaviral activity.

2. Materials and methods {#s0010}
========================

2.1. Preparation of *A. katumadai* extracts and fractions {#s0015}
---------------------------------------------------------

The dried seeds (4.8 kg) of *A. katsumadaii* were ground and macerated with ethanol (1.5 L × 20) for one week at room temperature, and then filtered and the clarified solvent was evaporated under reduced pressure to afford the ethanol extract (289 g, AK-1). The combined ethanol extract was dissolved in 2.0 L of a mixture of water and ethanol (1:9) and successively partitioned with EtOAc and water, yielding a layer of EtOAc (192 g, AK-2) and a layer of water (70 g, AK-3). The water soluble fraction AK-3 was subjected to dianion (HP-20) column chromatography, eluted with MeOH in water in a step-gradient manner from 20% to 100% to make five fractions \[20% methanol (AK-4): 3.9 g, 40% methanol (AK-5): 11.9 g, 60% methanol (AK-6): 32.7 g, 80% methanol (AK-7): 3.8 g, and 100% methanol (AK-8): 1.1 g\]. In order to obtain the polysaccharide fraction, we performed another procedure. The dried and pulverized seeds of *A. katsumadaii* (600 g) were mixed with 1.5 L of water and shaken at 80 °C for 12 h. The water extract (98 g, AK-9) was filtered through filter paper to remove debris, and the solution was precipitated by the addition of ethanol with a 1:4 ratio (v/v) at room temperature. After overnight precipitation, the precipitate was collected by centrifugation (12,000 rpm, 30 min at 4 °C) and washed with acetone and freeze-dried. This fractionation procedure was repeated three times. The corresponding fraction (56 g, AK-10) was light a brown powder (polysaccharide fraction), and the remaining supernatant was concentrated in a rotary evaporator under reduced pressure, yielding a supernatant fraction (28 g, AK-11).

2.2. Cells {#s0020}
----------

African rhesus monkey kidney (MA-104) cells were obtained from the American Type Culture Collection (ATCC CRL-2373.1; Manassas, VA, USA) and grown in Eagle's minimum essential medium (EMEM) supplemented with 5% fetal bovine serum (FBS), 100 U/mL penicillin, 100 μg/mL streptomycin, and 100 U/mL amphotericin B ([@b0110]).

2.3. Viruses {#s0025}
------------

KJ56-1 (bovine rotavirus, G8P\[7\]) and KJ25-1 (porcine rotavirus, G5P\[7\]) viruses isolated from fecal samples of Korean diarrheic calves and piglets were used in this study. These viruses were kindly provided by Dr. Kyoung-Oh Cho (Chonnam National University, South Korea). The rotaviruses were preactivated with 10 μg/mL trypsin (1:250; GIBCO Invitrogen Corporation, California) for 30 min at 37 °C before being inoculated onto confluent MA-104 cells. The infected cells were maintained in the presence of 1 μg/mL trypsin.

2.4. Cytotoxicity assay {#s0030}
-----------------------

MA-104 cells (1 × 10^5^  cells/well) were grown in 96-well plates for 48 h. The media were removed and replaced by new media containing serial dilutions of extracts under test. After incubation for 72 h, the media were discarded, and 5 μL of MTT (3-\[4,5-dimethylthiozol-2-yl\]-2,5-diphenyltetrazolium bromide; Sigma, St. Louis, MO) solution was added to each well. Plates were then incubated at 37 °C for 4 h. The solution was removed, and 100 μL of 0.04 M HCl-isopropanol was added to each well to dissolve formazan crystals ([Fig. 1](#f0005){ref-type="fig"} ). Using a microplate reader, the absorbance of each well was measured at 540 nm. After subtracting the background absorbance at 655 nm, the 50% cytotoxic concentration (CC~50~) of each extract was estimated by regression analysis.Fig. 1Anti-rotaviral assay strategies with *A. katumadai* (AK) extracts. Virus inoculation after virus incubation with AK extracts at 4 °C for 1 h for mixed treatment assay (A), treatment of AK extracts after viral infection for post treatment assay (B), and serial dose treatment of AK extracts for cytotoxicity assay (C).

2.5. Antiviral assay {#s0035}
--------------------

The antiviral assays used in this study have been previously described ([@b0015]), and the visualization of these assays was performed by neutral red method as briefly described.

In the mixed treatment assay: Each extract was mixed with a 0.01 multiplicity of infection (MOI) of the rotaviruses at various concentrations (0.1--133.3 μg/mL) and incubated at 4 °C for 1 h. The mixtures were inoculated in triplicates onto near confluent MA-104 cell monolayers (1 × 10^5^  cells/well) for 1 h with occasional rocking. The solution was removed and the cells replaced with EMEM containing 1 μg/mL trypsin. The cells were incubated for 72 h at 37 °C under 5% CO~2~ atmosphere until the cells in the infected, untreated control showed complete viral CPE by light microscopy ([Fig. 1](#f0005){ref-type="fig"}). The 50% effective concentration (EC~50~) was estimated by regression analysis.

In the post treatment assay: The rotaviruses at a 0.01 MOI were inoculated onto near confluent MA-104 cell monolayers (1 × 10^5^  cells/well) for 1 h with occasional rocking. The solution was removed and replaced by EMEM containing 1 μg/mL trypsin and various concentrations (0.1--133.3 μg/mL) of each extract in triplicates. The cells were cultured for 72 h at 37 °C until cells in the infected, untreated control well showed complete viral CPE by light microscopy. Neutral red solution was added to each well at 0.034% (w/v), and plates were incubated for 2 h at 37 °C in the absence of light. The neutral red solution was removed, cells were washed with PBS (pH 7.4), and destaining solution (1% glacial acetic acid, 49% H~2~O and 50% ethanol) was added. The plates were incubated in the dark for 15 min at room temperature, and the absorbance of each well at 540 nm was read using a microplate reader ([Fig. 1](#f0005){ref-type="fig"}). EC~50~ of each extracts was estimated by regression analysis.

2.6. Hemagglutination inhibition (HI) assay {#s0040}
-------------------------------------------

Standardized solutions of human red blood cells (hRBC, type O) were prepared according to the WHO manual 2002 (WHO, 2002). A 25 μL aliquot of rotavirus solution containing 4 HAU was mixed with 25 μL of serial dilutions in PBS (pH 7.4) of each extract and incubated for 1 h at 4 °C. Fifty microliters of a 1% (v/v) hRBC suspension was added, and the samples were incubated for 1 h at room temperature.

3. Results {#s0045}
==========

3.1. Cytotoxicity of *A. katsumadai* extracts in MA-104 cells {#s0050}
-------------------------------------------------------------

The cytotoxicity of AK extracts was evaluated by the MTT assay at 50% cell toxicity (CC~50~). Confluent MA-104 cells were incubated with EMEM media in the absence or presence of two fold diluted AK extracts (0.1--133.3 μg/mL) for 72 h, and the MTT reagents were treated onto the cells. Cytotoxicity among the six AK extracts showed a different concentration. AK-1 extract had low CC~50~ at 30.7 μg/mL, while AK-3, AK-5, AK-9, AK-10, and AK-11 with high CC~50~ at 70.1-over 133.3 μg/mL ([Table 1](#t0005){ref-type="table"}). Hence, experiments to evaluate the antiviral effect were carried out at AK extracts concentration of more than 90% cell viability in this study.

3.2. Antiviral activity of *A. katsumadai* on rotavirus adsorption {#s0055}
------------------------------------------------------------------

In the mixed treatment assay, after various concentrations of AK extracts and bovine rotavirus (G8P\[7\]) or porcine rotavirus (G5P\[7\]) were mixed and incubated, the mixtures were then inoculated into the confluent MA-104 cells. Of the 11 AK extracts, six extracts \[AK-1 (EtOH extract), AK-3 (H~2~O layer), AK-5 (40% methanol fraction), and AK-9-11 (H~2~O extract, polysaccharide fraction, supernatant fraction)\] exhibited inhibitory activities against G5P\[7\] rotavirus with EC~50~ values ranging from 0.7 ± 0.4 to 33.7 ± 6.5 μg/mL ([Table 1](#t0005){ref-type="table"} ). Against G8P\[7\] rotavirus, the AK-1, AK-3, and AK-5 extracts inhibited rotavirus infection with EC~50~ values of 8.4 ± 2.2 μg/mL, 6.5 ± 0.8 μg/mL, and 8.4 ± 5.0 μg/mL, respectively ([Table 1](#t0005){ref-type="table"}). The AK-1, AK-3, and AK-5 inhibited both G8P\[7\] and G5P\[7\] rotavirus infection in MA-104 cells. Whereas AK-9 (H~2~O extract), AK-10 (polysaccharide fraction), and AK-11 (supernatant fraction) only exhibited inhibitory effect against G5P\[7\] rotavirus. Extracts AK-3 and AK-5 showed the highest SI values of 10.8 and \>15.9 in G8P\[7\] and 100.1 and \>83.3 in G5P\[7\] rotavirus, respectively. Therefore, among the six AK extracts, AK-3 had the most inhibitory effect in the both G8P\[7\] and G5P\[7\] rotaviruses.Table 1*In vitro* anti-rotavirus activities of *A. katumadai* (AK) extracts against KJ56-1 (bovine rotavirus, G8P\[7\]) and KJ25-1 (porcine rotavirus, G5P\[7\]) on MA-104 cells using the mixed treatment assay.ExtractCC~50~ (μg/mL)[a](#tblfn1){ref-type="table-fn"}KJ56-1 (G8P\[7\])KJ25-1 (G5P\[7\])EC~50~ (μg/mL)[b](#tblfn2){ref-type="table-fn"}SI[c](#tblfn3){ref-type="table-fn"}EC~50~ (μg/mL)[b](#tblfn2){ref-type="table-fn"}SI[c](#tblfn3){ref-type="table-fn"}EtOH extract (AK-1)30.78.4 ± 2.23.78.9 ± 4.83.4H~2~O layer (AK-3)70.16.5 ± 0.810.80.7 ± 0.4100.140% methanol fraction (AK-5)\>133.38.4 ± 5.0\>15.91.6 ± 0.5\>83.3H~2~O extract (AK-9)\>133.3----33.7 ± 6.5\>4.0Polysaccharide fraction (AK-10)88.0----14.9 ± 2.65.9Supernatant fraction (AK-11)\>133.3----23.5 ± 1.8\>5.7[^1][^2][^3]

3.3. Antiviral activity of *A. katsumadai* on rotavirus replication {#s0060}
-------------------------------------------------------------------

In order to test the ability of the six AK extracts in inhibiting the replication of rotaviruses G8P\[7\] and G5P\[7\] in MA-104 cells, the post treatment assay was used. However, in contrast to the mixed treatment assay, no inhibitory effects against both rotaviruses were shown in the post treatment assay. These results indicate that AK extracts exert potent anti-rotaviral activity only before viral adsorption.

3.4. Hemagglutination inhibition activity {#s0065}
-----------------------------------------

To determine whether the AK extracts can block virus adsorption or cell entry, we evaluated whether AK extracts could inhibit rotavirus-induced hemagglutination by binding to O-type hRBCs. The six AK extracts completely inhibited viral adsorption onto hRBCs in both G8P\[7\] and G5P\[7\] rotaviruses at less than 11 μg/mL ([Fig. 2](#f0010){ref-type="fig"} ). Among the six extracts, AK-1, AK-3, and AK-5 particularly showed strong inhibition of hemagglutination with 0.7--4.3 μg/mL in both rotaviruses. AK-9 had a stronger inhibitory activity of hemagglutination in G8P\[7\] rotavirus than G5P\[7\] rotavirus contrary to the pretreatment assay result. AK-10 (7.0 and 7.4 μg/mL) and AK-11 (6.7 and 5.5 μg/mL) showed similar inhibitory concentrations to hemagglutination of G8P\[7\] and G5P\[7\] rotaviruses. As a result, six AK extracts were attributed mainly to having a strong interaction with hemagglutinin protein on the outer surface of rotavirus, resulting in blockage of viral adsorption.Fig. 2Hemagglutination inhibitory activity of *A. katumadai* (AK) extracts. Four HAU of bovine (G8P\[7\]) and porcine (G5P\[7\]) rotavirus were incubated with two fold dilutions of AK extracts or PBS (negative control), and human RBC (hRBC), for 1 h at room temperature. The minimum concentration of AK extract inhibiting the viral hemagglutination was determined. AK-1: EtOH extract; AK-3: H~2~O layer; AK-5: 40% methanol fraction; AK-9: H~2~O extract; AK-10: polysaccharide fraction; and AK-11: supernatant fraction.

4. Discussion and conclusion {#s0070}
============================

Various steps of the viral replication cycle are the targets of anti-rotavirus agents: adsorption, penetration into cells, uncoating, transcription, translation, assembly and viral release from infected cells ([@b0035]). We hypothesized that antiviral effects of AK extracts would act at the first two steps: (1) blockage of virus adsorption to cells and/or (2) inhibition of viral replication after entry cell. Time-of-addition experiments were performed to determine the stage at which AK extracts would exert inhibitory activities. The six AK extracts were incubated with MA-104 cells at two distinct time points: after incubation for 1 h at 4 °C with virus prior to virus infection (mixed treatment assay), and at 1 h after virus inoculation (post treatment assay) ([Fig. 1](#f0005){ref-type="fig"}).

Specifically, rotavirus entry into cells is a multistep process in which several interactions between its outer-layer proteins, VP4 and VP7, and the cell surface receptors including sialic acids (SA), integrins, and heat Shock Protein hsc70 occur ([@b0095]). VP4 is responsible for the hemagglutination (HA) activity and the binding SA which could be different according to rotavirus strains ([@b0065], [@b0095]). The HA activity of some rotavirus strains lead to the idea that SA is involved in the cell binding and infectivity of some animal rotavirus as in the case of influenza A virus, reovirus type 3, various coronaviruses, and Sendai virus ([@b0065]). Therefore, hemagglutination inhibition assay was employed to assess the inhibitory effects of AK extracts on viral adsorption to host cells. As a result, the six AK extracts completely inhibited viral adsorption onto hRBCs in both G8P\[7\] and G5P\[7\] rotaviruses below 11 μg/mL ([Fig. 2](#f0010){ref-type="fig"}). Particularly, AK-1, AK-3, and AK-5 showed strong inhibition of hemagglutination with EC~50~ values of 0.7--4.3 μg/mL in both rotaviruses. The HI assay results are in agreement with the mixed treatment assay results, indicating that the AK extracts could probably exert a potential anti-rotaviral activity via blockage of viral attachment to SA of host cell surfaces.

In conclusion, the present study has shown that AK extracts can inhibit both G8P\[7\] bovine rotavirus and G5P\[7\] porcine rotavirus infection probably by blocking viral adsorption leading to no virus entry into the cell. In this study, the AK extracts were classified as active compounds in the prevention of rotavirus infection; however, further studies about its specific mechanism of action in rotavirus infection should be explored.
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[^1]: CC~50~: mean (50%) value of cytotoxic concentration.

[^2]: EC~50~: mean (50%) value of effective concentration.

[^3]: SI: selective index, CC~50~/EC~50~.
